ArticleBMC psychiatry2025

Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization.

Lingfeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.